Insulet Corp (PODD)

HEALTH CARE: HEALTH CARE SUPPLIES
SIC: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS

100 NAGOG PARK ACTON, MA 01720

Insulet Corporation, a medical device company, engages in the development, manufacture, and marketing of insulin infusion system for people with insulin-dependent diabetes in the United States. It offers OmniPod Insulin Management System, which consists of its OmniPod disposable insulin infusion device and handheld wireless personal diabetes manager. The company's OmniPod Insulin Management System provides with a diabetes management solution, which provides lifestyle and other benefits and to expand the use of CSII therapy.

Data based on most recent fiscal year report
Market Cap4.951 Billion Shares Outstanding58.19 Million Avg Volume787.924 Thousand
1-Yr BETA vs S&P TR1.144 Current Ratio6.24 Quick Ratio5.85
View SEC Filings from PODD instead.
Q2 2019 All Institutions Hedge Funds 1
To trade PODD now:
Filers who had this stock in their top 10: 5 4 (0.41%)
13F Filers holding this stock: 269 37 (3.82%)
Aggregate 13F shares on 06/30/2019: 69.046 Million 5.723 Million
Aggregate 13F shares on 03/31/2019: 71.101 Million 4.351 Million
Percent change: -2.89% 31.55%
Funds creating new positions: 53 15
Funds Adding to an existing position: 86 4
Funds closing out their position: 36 5
Funds reducing their position: 90 16
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding PODD (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

649 total shares from 1 transactions

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

HOLLINGSHEAD JAMES PRESIDENT, SLEEP BUSINESS

  • Officer
85,301 2019-10-01 2

MINOGUE MICHAEL R CHAIRMAN, PRESIDENT, CEO

  • Officer
  • Director
500,198 2019-09-30 1

SCANNELL TIMOTHY J PRESIDENT AND COO

  • Officer
159,631 2019-09-16 1

LEMOINE DAVID A

  • Director
7,432 2019-09-05 3

PETROVIC SHACEY PRESIDENT AND CEO

  • Officer
  • Director
95,199 2019-09-03 9

SPEARS MICHAEL P SVP, RA AND COMPLIANCE

  • Officer
22,626 2019-08-15 5

LEVANGIE DANIEL J

  • Director
12,458 2019-07-31 0

ZAKRZEWSKI JOSEPH S

  • Director
84,547 2019-07-05 0

HOPFIELD JESSICA

  • Director
0 2019-06-12 1

MULLEN JAMES C

  • Director
0 2019-06-12 0

BUDDEN LAUREN VP, CAO AND CONTROLLER

  • Officer
3,721 2019-06-03 2

CRAWFORD SALLY

  • Director
28,469 2019-05-30 1

FALLON JOHN A.

  • Director
13,469 2019-05-30 4

NEVINNY CORINNE H

  • Director
4,913 2019-05-30 3

CHRISTENSEN BRET EVP AND CCO

  • Officer
13,809 2019-05-24 3

DEVLIN PETER

  • Director
0 2019-05-16 0

ROBERTS BRIAN K

  • Director
0 2019-05-16 0

ALPUCHE CHARLES EVP & CHIEF OPERATING OFFICER

  • Officer
39,244 2019-05-15 5

SOMMER REGINA O

  • Director
13,615 2019-05-09 0

SULLIVAN PATRICK J

  • Director
30,580 2019-04-30 0

COLLERAN DAVID SVP, SECRETARY AND GC

  • Officer
30,433 2019-04-02 7

KAPPLES JOHN W. SVP, SECRETARY AND GC

  • Officer
9,825 2019-04-01 2

ABDEL-MALEK AIMAN EVP & CHIEF TECHNOLOGY OFFICER

  • Officer
19,687 2019-03-28 6

MCMILLAN WAYDE D. EVP, CFO

  • Officer
24,727 2019-03-01 3

LEVITZ MICHAEL L SVP AND CFO

  • Officer
56,651 2019-02-27 3

BENJAMIN ERIC SVP, R&D, NEW PROD DEV. & COMM

  • Officer
13,331 2019-02-26 4

RYAN WILLIAM PATRICK CHIEF OPERATING OFFICER

  • Officer
0 2019-02-19 0

BOESS CARSTEN

0 2019-01-28 0

DORVAL ALLISON CHIEF FINANCIAL OFFICER

  • Officer
26,106 2019-01-11 0

THOMAS BRADLEY A EVP HUMAN RESOURCES

  • Officer
65,818 2018-03-29 0

BOESGAARD LARS VICE PRESIDENT, CFO

  • Officer
0 2017-03-24 0

DESISTO DUANE

  • Director
0 2016-10-28 0

NYE GORDON E

  • Director
877,785 2016-07-21 0

SOBIESKI STEVEN SVP & CHIEF FINANCIAL OFFICER

  • Officer
282,672 2015-11-06 0

DIEHL R ANTHONY SECRETARY AND GENERAL COUNSEL

  • Officer
40,854 2015-05-11 0

LIAMOS CHARLES T

  • Director
87,575 2015-04-01 0

LORTZ W MARK

  • Director
No longer subject to file 2015-01-06 0

HAYES KATHLEEN VICE PRESIDENT, HR

  • Officer
22,346 2014-09-19 0

WIELINSKI TRACEY HAAS VP, GLOBAL REGULATORY, CA, QA

  • Officer
24,000 2014-03-06 0

DEPIETRO RUTHANN VICE PRESIDENT OF QUALITY

  • Officer
18,351 2012-09-04 0

JAFFE ROSS A MD

  • Director
296,810 2012-02-17 0

KILEY ALISON

  • Director
  • 10% Owner
2,690,251 2011-08-08 0

MALAVE LUIS CHIEF OPERATING OFFICER

  • Officer
195,857 2010-03-01 0

CAMPBELL ROBERT VICE PRESIDENT FOR CLINICAL

  • Officer
63,633 2010-01-25 0

EICHHORN GARY

  • Director
70,749 2009-04-20 0

GVAZDAUSKAS SHAWNA SENIOR VICE PRESIDENT OF SALES

  • Officer
0 2009-02-26 0

SCHMID KEVIN VP OF OPERATIONS & ENGINEERING

  • Officer
0 2009-02-26 0

NG JASON VICE PRESIDENT OF ASIAN OPERAT

  • Officer
0 2009-02-26 0

GARIBOTTO JOHN VICE PRESIDENT OF RESEARCH

  • Officer
0 2009-02-26 0

ARTHUR WILLIAM D III V.P. OF BUSINESS DEVELOPMENT

  • Officer
0 2009-02-26 0

HOWE DAVID A VP OF HUMAN RESOURCES

  • Officer
0 2009-02-26 0

SUCHOFF ANDREW CHIEF HUMAN RESOURCES OFFICER

  • Officer
0 2008-03-27 0

SMITH JEFFEREY VICE PRESIDENT OF MARKETING

  • Officer
0 2008-03-12 0

PRISM VENTURE PARTNERS III A LP

PRISM INVESTMENT PARTNERS III LP

PRISM VENTURE PARTNERS III LLC

SEIFERT WILLIAM M

  • 10% Owner
1,200 2008-02-05 0

PRISM VENTURE PARTNERS III LP

  • 10% Owner
0 2008-02-05 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

PETROVIC SHACEY - Director - Officer PRESIDENT AND CEO

2019-09-03 S 649 $152.40 d 95,199 95,199.00 direct
Click here to report any possible errors with this stock listing.

Elevate your investments